Kinga K Hosszu

16PUBLICATIONS
169CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 07, 2026
Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

|Jun 29, 2026
ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

|May 01, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 06, 2026
Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Sigrun Einarsdottir, Teng Fei, Katina H Singh

|Dec 04, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garcés

Pageof 3

Frequent Collaborators

9 joint publications

Devin McAvoy

8 joint publications

Sergio Giralt

7 joint publications

Gunjan Shah

6 joint publications

Urvi S Shah